Cargando…

Advanced Nanotechnology for Enhancing Immune Checkpoint Blockade Therapy

Immune checkpoint receptor signaling pathways constitute a prominent class of “immune synapse,” a cell-to-cell connection that represses T-lymphocyte effector functions. As a possible evolutionary countermeasure against autoimmunity, this strategy is aimed at lowering potential injury to uninfected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cremolini, Chiara, Vitale, Emanuela, Rastaldo, Raffaella, Giachino, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998763/ https://www.ncbi.nlm.nih.gov/pubmed/33800368 http://dx.doi.org/10.3390/nano11030661

Ejemplares similares

Nanoengineering in Cardiac Regeneration: Looking Back and Going Forward
por: Cristallini, Caterina, et al.
Publicado: (2020)

Dual Role of Autophagy in Regulation of Mesenchymal Stem Cell Senescence
por: Rastaldo, Raffaella, et al.
Publicado: (2020)

Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology
por: Liu, Zefan, et al.
Publicado: (2022)

Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions
por: Perveen, Sadia, et al.
Publicado: (2021)

Role of Chaperone-Mediated Autophagy in Ageing Biology and Rejuvenation of Stem Cells
por: Vitale, Emanuela, et al.
Publicado: (2022)

Apelin-13 Increases Functional Connexin-43 through Autophagy Inhibition via AKT/mTOR Pathway in the Non-Myocytic Cell Population of the Heart
por: Vitale, Emanuela, et al.
Publicado: (2022)

Silica Nanoparticle Internalization Improves Chemotactic Behaviour of Human Mesenchymal Stem Cells Acting on the SDF1α/CXCR4 Axis
por: Vitale, Emanuela, et al.
Publicado: (2022)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Direct Reprogramming of Resident Non-Myocyte Cells and Its Potential for In Vivo Cardiac Regeneration
por: Perveen, Sadia, et al.
Publicado: (2023)

The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)

Acquired Resistance to Immune Checkpoint Blockade Therapies
por: Zhao, Xianda, et al.
Publicado: (2020)

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
por: Ho, Rachel L. Y., et al.
Publicado: (2021)

APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure
por: Rossin, Daniela, et al.
Publicado: (2023)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy
por: Turinetto, Valentina, et al.
Publicado: (2016)

Immune checkpoint blockade therapy for bladder cancer treatment
por: Kim, Jayoung
Publicado: (2016)

Advances in the management of gastrointestinal cancers—an upcoming role of immune checkpoint blockade
por: Goel, Gaurav, et al.
Publicado: (2015)

Microbial biomarkers for immune checkpoint blockade therapy against cancer
por: Adachi, Keishi, et al.
Publicado: (2018)

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
por: Wang, Hao, et al.
Publicado: (2019)

Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy
por: Grottoli, Melania, et al.
Publicado: (2022)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
por: Hijazi, Assia, et al.
Publicado: (2023)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy
por: Kawanabe-Matsuda, Hirotaka, et al.
Publicado: (2022)

Immune Checkpoint Blockade: A New Paradigm in Treating Advanced Cancer
por: Kreamer, Kristen M.
Publicado: (2014)

Targeting Cancer Cells Overexpressing Folate Receptors with New Terpolymer-Based Nanocapsules: Toward a Novel Targeted DNA Delivery System for Cancer Therapy
por: Bellotti, Elena, et al.
Publicado: (2021)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Predictors of responses to immune checkpoint blockade in advanced melanoma
por: Jacquelot, N., et al.
Publicado: (2017)

Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients
por: Perrotta, Fabio, et al.
Publicado: (2019)

Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade
por: Shin, Min Hwa, et al.
Publicado: (2020)

Rethinking immune checkpoint blockade: ‘Beyond the T cell’
por: Liu, Xiuting, et al.
Publicado: (2021)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma
por: Lin, Adam Yuh, et al.
Publicado: (2022)

TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
por: Chiang, Eugene Y, et al.
Publicado: (2022)

Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
por: Li, Song, et al.
Publicado: (2023)

Gastric Cancer in the Era of Immune Checkpoint Blockade
por: Figueroa-Protti, Lucía, et al.
Publicado: (2019)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
por: Andersson, Patrik, et al.
Publicado: (2019)

Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy
por: Peng, Zhi-Peng, et al.
Publicado: (2023)

Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
por: Swart, Maarten, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7a7odeklg3voj6gmlsqklttv6d